Index. B Bacillary angiomatosis versus Kaposi s sarcoma, 515 with HIV/AIDS, Bacterial folliculitis, versus pruritic papular eruption, 455

Size: px

Start display at page:

Download "Index. B Bacillary angiomatosis versus Kaposi s sarcoma, 515 with HIV/AIDS, Bacterial folliculitis, versus pruritic papular eruption, 455"

Arron Singleton
5 years ago
Views:

1 Dermatol Clin 24 (2006) Index Note: Page numbers of article titles are in boldface type. A Actinic dermatitis, with HIV/AIDS, 446 Acute retroviral syndrome, acquisition of, 432 clinical features of, diagnosis of, 434 differential diagnosis of, 434 early identification of, 432 gastrointestinal complications of, 432 genitourinary complications of, 432 management of, highly active retroviral therapy in, 435 mucosal ulcers in, 432 neurologic complications of, 432 pathogenesis of, psychological impact of, pulmonary complications of, 432 transmission of, 433 Acyclovir, for varicella zoster virus, 477 Africa, HIV/AIDS epidemiology in. See HIV/ AIDS, global epidemiology of. AIDS. See HIV/AIDS. Alitretinoin gel, for Kaposi s sarcoma, 517 Anogenital lesions, in Kaposi s sarcoma, 513 Antimonial agents, for leishmaniasis, 487 Antiretroviral therapy, adjunctive, 542 adverse reactions to, 542 and hyperlipidemia, 543 and hypersensitivity syndrome, 542 and insulin resistance, 543 and lactic acidosis, and lipodystrophy, choice of regimen for, fusion inhibitors, 540 nonnucleoside reverse transcriptase inhibitors, 540 nucleoside reverse transcriptase inhibitors, protease inhibitors, 540 classes of, 538 combination therapy in, 542 dosing schedules and restrictions in, effects of, on Kaposi s sarcoma, 510, 515, 516 goals of, 544 highly active. See Highly active antiretroviral therapy. initiation of, metabolic complications of, 542 principles of, resistance testing in, resistance to, Antituberculosis drugs, adverse reactions to, Aqueous crystalline penicillin G, for neurosyphilis, 504 Argentina, HIV/AIDS epidemiology in, 416 Arthropod bites, versus pruritic papular eruption, 455 Arthropod hypersensitivity, and pruritic papular eruption, Asia, HIV/AIDS epidemiology in, Atopic dermatitis, with HIV/AIDS, 442 Australia, HIV/AIDS epidemiology in, 417 Azidothymidine, for HIV/AIDS, dermatologist epidemic watcher s perspective on, 409 Azithromycin, for syphilis, B Bacillary angiomatosis versus Kaposi s sarcoma, 515 with HIV/AIDS, Bacterial folliculitis, versus pruritic papular eruption, /06/$ - see front matter Ó 2006 Elsevier Inc. All rights reserved. doi: /s (06) derm.theclinics.com

2 572 INDEX Bacterial infections, with HIV/AIDS. See Cutaneous infections. Bahamas, HIV/AIDS epidemiology in, 415 Baltic states, HIV/AIDS epidemiology in, 415 Bartonella infections, with HIV/AIDS, Basal cell carcinoma. See Skin cancer. Benzathine penicillin G, for syphilis, 503, 504 Biopsy, skin, for acute retroviral syndrome, 434 Botryomycosis, with HIV/AIDS, 474 Brazil, HIV/AIDS epidemiology in, 416 Bullous drug reactions, in HIV infection, 462 Buruli ulcers, with HIV/AIDS, 485 C Candidiasis, with HIV/AIDS, Cardiovascular syphilis, with HIV infection, , 504 Caribbean, HIV/AIDS epidemiology in, CD4 lymphocyte count, and skin cancer, 522, 523 Ceftriaxione, for syphilis, 503 Central Africa, HIV/AIDS epidemiology in, Central Asia, HIV/AIDS epidemiology in, Central Europe, HIV/AIDS epidemiology in, Cerebrospinal fluid studies for neurosyphilis, 502 for syphilis, 504 Cervical cancer, with HIV/AIDS, Cervical intraepithelial neoplasia, with HIV/ AIDS, Chemotherapy, for Kaposi s sarcoma, 516, 517 China, HIV/AIDS epidemiology in, Coccidioidomycosis, with HIV/AIDS, Cryptococcosis syndrome and, 554, with HIV/AIDS, Cuba, HIV/AIDS epidemiology in, Cutaneous infections, with HIV/AIDS, bacterial, bacillary angiomatosis, Staphylococcus aureus, fungal, candidiasis, coccidioidomycosis, cryptococcosis, dermatophytosis, histoplasmosis, mycobacterial, 485 Penicillium marneffei, 483 Pneumocystis jiroveci, 483 parasitic, leishmaniasis, scabies, viral, cytomegalovirus, 478 Epstein-Barr virus, 478 herpes simplex virus, human papillomavirus, molluscum contagiosum virus, varicella zoster virus, Cytomegalovirus, with HIV/AIDS, 478 D Demodex folliculorum infestations, versus pruritic papular eruption, 453, 455 Dermatitis, with HIV/AIDS, , 446 Dermatomal zoster, with HIV/AIDS, Dermatophytosis, with HIV/AIDS, Dermatoses, inflammatory noninfectious. See Inflammatory noninfectious dermatoses. Dominican Republic, HIV/AIDS epidemiology in, 415 Doxorubicin, for Kaposi s sarcoma, 516, 517 Doxycycline, for syphilis, 503 Drug hypersensitivity syndrome antiretroviral therapy and, 542 in HIV infection, , 466 E East Africa, HIV/AIDS epidemiology in, 425 Eastern Europe, HIV/AIDS epidemiology in, Eczema, with HIV/AIDS, Enfuvirtide, for HIV infection, mechanism of action of, 540

3 Enzyme-linked immunosorbent assays, for acute retroviral syndrome, 434 Eosinophilic folliculitis, with HIV/AIDS. See Inflammatory noninfectious dermatoses. Epstein-Barr virus, with HIV/AIDS, 478 Ethiopia, HIV/AIDS epidemiology in, 425 Europe, HIV/AIDS epidemiology in, F Fat-redistribution syndrome, antiretroviral therapy and, Fluconazole, resistance to, in HIV/AIDS, 484 Fluorescent treponemal antibody absorption test, for syphilis, Folliculitis eosinophilic, with HIV/AIDS. See Inflammatory noninfectious dermatoses. versus pruritic papular eruption, 455 Fungal infections, with HIV/AIDS. See Cutaneous infections. Fusion inhibitors, mechanism of action of, 540 G Gastrointestinal complications, of acute retroviral syndrome, 432 Genital ulcers, with HIV/AIDS, 475 Genitourinary complications, of acute retroviral syndrome, 432 Genotypic resistance assays, in drug resistance testing, 544 Granulomatous foreign-body reactions, immune reconstitution inflammatory syndrome and, 555, Gummatous syphilis, with HIV infection, 500, 504 H Haiti, HIV/AIDS epidemiology in, 415 Herpes simplex virus infections syndrome and, 551, 552, with HIV/AIDS, Herpes zoster syndrome and, 552, with HIV/AIDS, in children, 534 INDEX 573 Highly active antiretroviral therapy and syndrome. See Immune reconstitution inflammatory syndrome. dermatologist epidemic watcher s perspective on, effects of on cervical intraepithelial neoplasia, 479 on cryptococcosis, on leishmaniasis, 487 on skin cancer, 523, 525 on varicella zoster virus, 477 for acute retroviral syndrome, 435 in children, Histoplasmosis syndrome and, 554, with HIV/AIDS, HIV/AIDS adverse drug reactions in, , 542 bullous reactions, 462 causality in, classification of, definition of, 459 diagnosis of, 461 dosage schedules and, 469 drug hypersensitivity syndrome, , 466, 542 drug provocation tests for, epidemiology of, immune stimulation and, 470 in tuberculosis patients, major histocompatibility complex and, 470 morbilliform exanthematous reactions, pathogenesis of, 469 Stevens-Johnson syndrome, , T-cell activation and, 470 to antituberculosis drugs, 468 to trimethoprim-sulfamethoxazole, toxic epidermal necrolysis, , and acute retroviral syndrome. See Acute retroviral syndrome. and skin cancer. See Skin cancer. cutaneous infections with. See Cutaneous infections. dermatologist epidemic watcher s perspective on, beginning of pandemic, 407 pandemic in retrospect,

4 574 INDEX HIV/AIDS (coninued) agent, 409 birth, 408 blood risk, 409 gender spread, 409 geographical spread, global disease and response, 410 lost generation and orphans, 409 origins, 408 prevention, 410 stigma, 409 treatment, prepandemic, resources, 411 skin disease as marker, 408 spin-off benefits, 410 global epidemiology of, Asia, Caribbean, Eastern Europe and Central Asia, Latin America, 416 Middle East and North Africa, 417 North America and Western and Central Europe, Oceania, 417 prevention strategies in, primary, 418 secondary, 418 tertiary, 418 sub-saharan Africa, 413, , cost-effective interventions in, cutaneous diseases in, East Africa, 425 expanding access to treatment, 426 factors contributing to, in women, 426 inadequate health care and, 421 mortality rates from, 421 prevention strategies in, 426 regional trends in, Southern Africa, West and Central Africa, in children, epidemiology of, highly active antiretroviral therapy for, syndrome in, immune status in, skin disease as indicator of, in sub-saharan Africa, incidence of, 532 vertical transmission of, 532 inflammatory noninfectious dermatoses with. See Inflammatory noninfectious dermatoses. Kaposi s sarcoma with. See Kaposi s sarcoma. pruritic papular eruption with. See Pruritic papular eruption. syphilis with. See Syphilis. Human herpesvirus 8, and Kaposi s sarcoma, , 552, Human papillomavirus, with HIV/AIDS, Hydroxyurea, with antiretroviral therapy, 542 Hyperlipidemia, antiretroviral therapy and, 543 I Imiquimod, for human papillomavirus, 479 Immune dysregulation, and pruritic papular eruption, 450 Immune reconstitution inflammatory syndrome, and cryptococcosis, 554, and eosinophilic folliculitis, 554, and granulomatous foreign-body reactions, 555, and herpes simplex virus infections, 551, 552, and herpes zoster virus, 552, and histoplasmosis, 554, and Kaposi s sarcoma, 552, and leishmaniasis, 555, 565 and leprosy, 553, and lupus erythematosus, , 565 and molluscum contagiosum, 553, 559 and mycobacterial infections, 553, and sarcoidosis, 555, 564 and tuberculosis, 553, 561 and warts, 553 clinical features of, 550 definition of, 549 diagnosis of, 551 historical aspects of, immunopathogenesis of, in children, incidence of, 550 management of, 551 risk factors for, 551 Immunoglobulin E, in pruritic papular eruption, 452 Immunomodulatory drugs, with antiretroviral therapy, 542 India, HIV/AIDS epidemiology in, 414

5 INDEX 575 Infections, cutaneous, with HIV/AIDS. See Cutaneous infections. Inflammatory noninfectious dermatoses, with HIV/AIDS, atopic dermatitis, 442 chronic actinic dermatitis, 446 eosinophilic folliculitis, clinical features of, differential diagnosis of, 430, 453 syndrome and, 554, management of, pathogenesis of, 439 pathology of, 439 photosensitivity, pruritus, psoriasis, Reiter s syndrome, seborrheic dermatitis, xerosis, 442 Insulin resistance, antiretroviral therapy and, 543 Interferons, in pruritic papular eruption, 452 Interleukins, in pruritic papular eruption, 452 Isotretinoin, for eosinophilic folliculitis, 440 Itraconazole for eosinophilic folliculitis, 440 to prevent histoplasmosis, in HIV/AIDS, J Jarisch-Herxheimer reaction, to syphilis treatment, 503 K Kaposi s sarcoma, anogenital lesions in, 513 antiretroviral agents and, 510, 515, 516 classification of, 509 clinical features of, cutaneous lesions in, diagnosis of, differential diagnosis of, 514 epidemiology of, 510 etiopathogenesis of, histology of, 514 human herpesvirus 8 and, , 552, syndrome and, 552, in children, 514 lymphadenopathic, 514 management of, chemotherapy in, 517 experimental therapies in, for localized mucocutaneous lesions, 517 in developing countries, 518 radiation therapy in, 517 retinoids in, 517 oral mucosal lesions in, 513 prognosis for, 515 pulmonary lesions in, staging of, 515 visceral lesions in, , 515 Kenya, HIV/AIDS epidemiology in, 425 L Lactic acidosis, antiretroviral therapy and, Latin America, HIV/AIDS epidemiology in, 416 Leishmaniasis syndrome and, 555, 565 with HIV/AIDS, Leprosy, syndrome and, 553, Lipid abnormalities, antiretroviral therapy and, 543 Lipodystrophy, antiretroviral therapy and, Lues maligna, with HIV infection, 499 Lupus erythematosus, immune reconstitution inflammatory syndrome and, , 565 Lymphadenopathy, with Kaposi s sarcoma, 514 Lymphedema, with Kaposi s sarcoma, Lymphoma, cutaneous, with HIV infection, M Major histocompatibility complex, and adverse drug reactions, 470 Malignant syphilis, with HIV infection, 499 Melanoma, with HIV infection, 524 Merkel cell carcinoma, with HIV infection, 525 Metabolic complications, of antiretroviral therapy, 542 Metformin, for lipodystrophy, 544

6 576 INDEX Methicillin-resistant Staphylococcus aureus infections, risk of, with HIV/AIDS, 474 Mexico, HIV/AIDS epidemiology in, 416 Middle East, HIV/AIDS epidemiology in, 417 Miliary tuberculosis, with HIV/AIDS, 485 Molluscum contagiosum syndrome and, 553, 559 with HIV/AIDS, Morbilliform exanthematous drug reactions, in HIV infection, Mucocutaneous leishmaniasis, with HIV/AIDS, 486 Mucocutaneous lesions in HIV/AIDS, in children, 533 in Kaposi s sarcoma, 517 Mucosal ulcers, in acute retroviral syndrome, 432 Mycobacterial infections syndrome and, 553, with HIV/AIDS, 485 N Neuralgia, postherpetic, with HIV/AIDS, 477 Neurologic complications, of acute retroviral syndrome, 432 Neurosyphilis, with HIV infection, 501, 502, 504 Nodular prurigo, versus pruritic papular eruption, 455 Nonnucleoside reverse transcriptase inhibitors, mechanism of action of, 540 Nontreponemal tests, for syphilis, North Africa, HIV/AIDS epidemiology in, 417 North America, HIV/AIDS epidemiology in, Nucleoside reverse transcriptase inhibitors, mechanism of action of, O Oceania, HIV/AIDS epidemiology in, 417 Ocular syphilis, with HIV infection, Oral mucosal lesions, in Kaposi s sarcoma, 513 Organ transplant recipients, skin cancer in. See Skin cancer. P p24 enzyme immunoassays, for acute retroviral syndrome, 434 Papua New Guinea, HIV/AIDS epidemiology in, 417 Papular urticaria, versus pruritic papular eruption, 455 Parasitic infections, with HIV/AIDS. See Cutaneous infections. Pegylated liposomal doxorubicin, for Kaposi s sarcoma, 516, 517 Penicillium marneffei infections, with HIV/AIDS, 483 Pentoxifylline, for pruritic papular eruption, 455 Phenotypic resistance assays, in drug resistance testing, Photosensitivity, with HIV/AIDS, Pityrosporal folliculitis, versus pruritic papular eruption, 455 Pneumocystis jiroveci infections, with HIV/AIDS, 483 Podophyllotoxin, for human papillomavirus, 479 Postherpetic neuralgia, with HIV/AIDS, 477 Procaine penicillin, for neurosyphilis, 504 Protease inhibitors, mechanism of action of, 540 Pruritic papular eruption, with HIV infection, arthropod hypersensitivity in, clinical features of, differential diagnosis of, etiology of, hematologic and immunologic findings in, immune dysregulation in, 450 management of, 455 pathology of, prevalence of, 450 Pruritus, with HIV/AIDS, Psoriasis, with HIV/AIDS, Pulmonary complications, of acute retroviral syndrome, 432

7 INDEX 577 Pulmonary lesions, in Kaposi s sarcoma, R Radiation therapy, for Kaposi s sarcoma, 517 Reiter s syndrome, with HIV/AIDS, Retinoids, for Kaposi s sarcoma, 517 Ritonavir, for HIV infection, 542 Rosiglitazone, for lipodystrophy, 544 Russian Federation, HIV/AIDS epidemiology in, S Sarcoidosis, syndrome and, 555, 564 Sarcoptes scabiei infections, with HIV/AIDS, Scabies, with HIV/AIDS, Seborrheic dermatitis, with HIV/AIDS, Skin biopsy, for acute retroviral syndrome, 434 Skin cancer, HIV infection and, cutaneous lymphoma, effect on natural history, 524 highly active antiretroviral therapy and, 525 in organ transplant recipients, highly active antiretroviral therapy and, 523 level of immunosuppression and, 522, 523 management of, 525 melanoma, 524 Merkel cell carcinoma, 525 nonmelanoma cancer, risk factors for, Southern Africa, HIV/AIDS epidemiology in, Squamous cell carcinoma. See Skin cancer. Staphylococcus aureus infections, with HIV/ AIDS, Stevens-Johnson syndrome, with HIV infection, , Sub-Saharan Africa, HIV/AIDS epidemiology in. See HIV/AIDS, global epidemiology of. Syphilis, with HIV infection, cardiovascular syphilis, , 504 clinical features of, 498 diagnosis of, epidemiology of, gummatous syphilis, 500, 504 latent syphilis, 500, malignant syphilis, 499 management of, neurosyphilis, 501, 502, 504 ocular syphilis, pathology of, primary syphilis, 498, secondary syphilis, , tertiary syphilis, , 504 Systemic lupus erythematosus, immune reconstitution inflammatory syndrome and, 555, 565 T Tanzania, HIV/AIDS epidemiology in, 425 T-cell activation, and adverse drug reactions, 470 T-cell counts, in pruritic papular eruption, 452 Toxic epidermal necrolysis, with HIV infection, , Treponemal tests, for syphilis, Trichophyton rubrum infections, with HIV/AIDS, 484 Trimethoprim-sulfamethoxazole, adverse reactions to, Tuberculosis syndrome and, 553, 561 with HIV/AIDS, 485 Tumid lupus, immune reconstitution inflammatory syndrome and, 555, 565 U Uganda, HIV/AIDS epidemiology in, 425 Ukraine, HIV/AIDS epidemiology in, 415 Ulcers Buruli, with HIV/AIDS, 485 genital, with HIV/AIDS, 475 mucosal, with acute retroviral syndrome, 432 UVB phototherapy, for pruritic papular eruption, 455

8 578 INDEX V Vaccines for human papillomavirus, for varicella zoster virus, 477 Varicella zoster virus, with HIV/AIDS, Viral infections, with HIV/AIDS. See Cutaneous infections. Virtual phenotypic resistance assays, in drug resistance testing, 545 Visceral leishmaniasis syndrome and, 563 with HIV/AIDS, Visceral lesions, in Kaposi s sarcoma, 513, 515 W Warts, syndrome and, 553 West Africa, HIV/AIDS epidemiology in, Western blot tests, for acute retroviral syndrome, 434 X Xerosis, with HIV/AIDS, 442 Z Zimbabwe, HIV/AIDS epidemiology in, 425

Second Joint Conference 0f the British HIV Association [BHIVA] and the British Association for Sexual Health and HIV [BASHH]

Second Joint Conference 0f the British HIV Association [BHIVA] and the British Association for Sexual Health and HIV [BASHH] 20-23 April 2010, Manchester Central Convention Complex SECOND JOINT CONFERENCE